James Gordon CFA
Stock Analyst at Barclays
(3.12)
# 2,449
Out of 4,334 analysts
109
Total ratings
52.6%
Success rate
6%
Average return
Main Sectors:
Stocks Rated by James Gordon CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: 0MGB Genmab A/S | Rated: Buy | $2,500 | $1,723.63 | +45.04% | 6 | May 22, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | $300 | $289.00 | +3.81% | 16 | May 19, 2026 | |
| SWX: GALD Galderma Group AG | Maintained: Buy | $200 | $158.65 | +26.06% | 20 | May 18, 2026 | |
| LON: 0QW0 argenx SE | Reiterated: Buy | $900 | $697.71 | +28.99% | 11 | May 11, 2026 | |
| SWX: SDZ Sandoz Group AG | Upgraded: Buy | $75 | $64.44 | +16.39% | 6 | May 5, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Buy | $165 | $13,916.00 | -98.81% | 9 | Apr 29, 2026 | |
| LON: GSK GSK plc | Maintained: Sell | $19 | $1,915.00 | -99.01% | 15 | Apr 28, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Buy | $410 | $334.50 | +22.57% | 12 | Apr 28, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Hold | $120 | $119.46 | +0.45% | 6 | Apr 28, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | $85 | $77.46 | +9.73% | 6 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $14 | $1,459.00 | -99.07% | 2 | Mar 2, 2026 |
Genmab A/S
May 22, 2026
Rated: Buy
Price Target: $2,500
Current: $1,723.63
Upside: +45.04%
Novo Nordisk A/S
May 19, 2026
Maintained: Hold
Price Target: $300
Current: $289.00
Upside: +3.81%
Galderma Group AG
May 18, 2026
Maintained: Buy
Price Target: $200
Current: $158.65
Upside: +26.06%
argenx SE
May 11, 2026
Reiterated: Buy
Price Target: $900
Current: $697.71
Upside: +28.99%
Sandoz Group AG
May 5, 2026
Upgraded: Buy
Price Target: $75
Current: $64.44
Upside: +16.39%
AstraZeneca PLC
Apr 29, 2026
Maintained: Buy
Price Target: $165
Current: $13,916.00
Upside: -98.81%
GSK plc
Apr 28, 2026
Maintained: Sell
Price Target: $19
Current: $1,915.00
Upside: -99.01%
Roche Holding AG
Apr 28, 2026
Maintained: Buy
Price Target: $410
Current: $334.50
Upside: +22.57%
Novartis AG
Apr 28, 2026
Maintained: Hold
Price Target: $120
Current: $119.46
Upside: +0.45%
Sanofi
Apr 23, 2026
Maintained: Hold
Price Target: $85
Current: $77.46
Upside: +9.73%
Mar 2, 2026
Maintained: Sell
Price Target: $14
Current: $1,459.00
Upside: -99.07%